Ignite Creation Date:
2024-05-06 @ 10:33 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03280030
Status:
COMPLETED
Last Update Posted:
2023-04-19
First Post:
2017-09-08
Brief Title:
A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-08
First Submit QC Date:
September 8 2017
Study First Post Date:
2017-09-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-18
Last Update Post Date:
2023-04-19
Last Update Post Date Type:
ACTUAL